LONDON BROKER RATINGS: AstraZeneca cut; Barclays raises Centrica
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
----------
FTSE 100
----------
Deutsche Bank Research cuts AstraZeneca to 'sell' (hold) - price target 10,500 (11,000) pence
----------
Goldman Sachs raises Entain price target to 1,100 (1,080) pence - 'buy'
----------
Deutsche Bank Research raises Entain price target to 1,158 (1,122) pence - 'buy'
----------
JPMorgan raises Entain price target to 1,150 (1,110) pence - 'neutral'
----------
Barclays raises Centrica to 'overweight' (equal weight) - price target 210 (180) pence
----------
FTSE 250
----------
Deutsche Bank Research cuts Morgan Advanced price target to 205 (235) pence - 'hold'
----------
SMALL CAP
----------
Berenberg starts Filtronic with 'buy' - price target 196 pence
----------
Berenberg cuts Sabre Insurance price target to 190 (200) pence - 'buy'
----------
RBC cuts Brooks Macdonald price target to 1,850 (1,900) pence - 'sector perform'
----------
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Articles
UK homes for sale hit eight-year high at start of 2026 says Zoopla
(Alliance News) - Some home buyers could be seeing the biggest choice of properties for sale in a new year...
IN BRIEF: JTC shareholders back GBP2.7 billion buyout
JTC PLC - Jersey-based professional services company - Majority of voters at court and general meetings support the acquisition of...
EARNINGS AND TRADING: Titon profit swing; Brooks Macdonald funds rise
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported...
